Last reviewed · How we verify
NCT05324670
Title: "Intervention Based on Didactic Model for Suicidal Behavior in the Framework of Impulsivity and Ideations."
NA trial testing Didactic model for suicidal behavior in the framework of impulsivity and ideations in Suicidal Ideation and Behavior in 150 participants. Status unknown.
1 June 2022
Quick facts
| Lead sponsor | International Islamic University, Islamabad |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 1 August 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 August 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Didactic model for suicidal behavior in the framework of impulsivity and ideations
Conditions studied
- Suicidal Ideation and Behavior — all drugs for Suicidal Ideation and Behavior →
- Impulsivity — all drugs for Impulsivity →
Sponsor
International Islamic University, Islamabad
Who can join
Adults 12 to 25, male only, with Suicidal Ideation and Behavior or Impulsivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Suicide has become a major public health problem among young people around the world. This study will examine the effects of higher secondary school-based suicide prevention (HSSSP) program on youth suicidal thoughts and impulsive behavior (STIB). Therefore, the purpose of this study is to examine the effects of didactic approach for youth STIB on the HSSSP program. This study is designed to address this issue at the secondary school level. Therefore, this research is divided into two studies. In the first study, our goal was to arrange a Baseline assessment for the screening process of adolescents at risk of suicide. while in second study we aim to implement a didactic approach based on religious teachings and culture milieu and examine its effects as an evidence based suicide prevention program.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Prevention of self-harm and suicide in young people up to the age of 25 in education settings.
Sharma V, Marshall D, Fortune S, Prescott AE, et al · · 2024 · cited 5× · PMID 39704320 · DOI 10.1002/14651858.cd013844.pub2 -
A randomised controlled trial of a culturally adapted didactic strategy for suicidal ideation (CADS-S) in young male students in Pakistan.
Abdullah M, Khalily MT, Hallahan B. · · 2026 · PMID 41772830 · DOI 10.1017/ipm.2026.10172
Verify or expand the search:
- PubMed search for NCT05324670
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicidal Ideation and Behavior
Currently open trials in the same condition.
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07321171 — Stepped-Care for Suicidal Youth and Children · NA · recruiting
Other International Islamic University, Islamabad trials
Trials by the same sponsor.
- NCT05613595 — Effectiveness of Positive Psychotherapy on Mental Wellbeing Among Caregivers of Cerebral Palsy Children · NA · unknown
- NCT04981522 — Community Based Psychological Intervention For Persons Living With Disabilities · NA · completed
- NCT04513756 — Efficacy of Community Reinforcement Approach (CRA) in the Treatment of Cannabis Users · NA · unknown
- NCT04126252 — Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction · NA · completed
- NCT04179747 — Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05324670 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by International Islamic University, Islamabad
- Last refreshed: 22 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05324670.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing